Quotient Sciences is a global drug development accelerator, operating from state-of-the-art development, manufacturing and clinical testing facilities in the U.S. and U.K. We have over 30 years of experience and have worked on over 3,000 molecules across all stages of development.
The Quotient Sciences Translational Pharmaceutics® platform is our flagship approach to drug development that integrates formulation development, real-time manufacturing and clinical testing activities.
We help take the hassle out of managing multiple outsourcing partners. Your program will be led by a single project manager who will manage an integrated cross-functional project team focused on delivering all of the components of traditional CDMO and CRO services — allowing you to capture multiple efficiencies.
On average, our customers save 12 months or more of development time, translating into into R&D cost savings as well as the benefit of getting products to market much sooner.
Integrated development platform that is proven to reduce timelines by >12 months.
Clinical trial supplies for oral, injectable and inhaled dosage forms.
Phase I healthy volunteer studies & 14C Human ADME.
Tech transfer, Process Scale-Up & Optimization, Lifecycle Management.
PR&D, Custom Synthesis and drug substance characterization.
Simple & complex dosage forms: PIB, PIC, Tablets, Poorly Soluble, Modified-Release, Pediatrics.
Rapid bioanalytical data in discovery, pre-clinical & clinical.
Rapid access to clinical data & results to accelerate drug development.
Holistic scientific advice at each stage of drug development.